Navigation Links
Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr.
Date:11/16/2011

BOONTON, N.J., Nov. 16, 2011 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced the appointment of Thomas J. Sabatino, Jr. to its Board of Directors.

Mr. Sabatino is currently Executive Vice President and General Counsel for Walgreen Co., (NYSE: WAG) (NASDAQ: WAG), based in Deerfield, IL.  He joined Walgreens in September 2011 after having held general counsel roles with United Airlines, Inc., Schering-Plough Corporation, Baxter International Inc., and American Medical International, Inc.

Richard Levy, Chairman of the Board at Unigene and Managing Partner and Founder of Victory Park Capital, the Chicago-based alternative investment firm, which provided Unigene with critical new capital during the company's 2010 debt restructuring, said, "We are proud to have Tom join Unigene's Board of Directors. His extensive industry experience and impressive track record – specifically, his knowledge of the legal and regulatory landscape for pharmaceutical companies – will be invaluable as Unigene continues to execute against its business transformation.  Tom brings a wealth of contacts, knowledge and insight that will strengthen our board and be instrumental in guiding the business through market-leading clinical developments of orally-delivered, peptide-based therapeutics."

Thomas J. Sabatino, Jr., stated, "Unigene has emerged as the leading oral peptide delivery company with validated technology platforms.  I am extremely impressed with the management team's progress thus far.  The team's unwavering commitment to the solid execution of their strategy has resulted in tangible results over the past year as well as se
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
2. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
3. Unigene Reports Third Quarter 2011 Financial Results
4. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
5. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
6. Pepscan Therapeutics Strengthens Management Team
7. Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering
8. Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores
9. Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo
10. Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation
11. PAREXEL Opens New Office in Japan and Further Strengthens Leading Presence in Asia/Pacific Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... July 1, 2015 Dynatronics Corporation (the ... marketer of rehabilitation and physical therapy products, announced ... placement financing led by affiliates of Prettybrook Partners ... focused on the healthcare industry. The financing provides ... and pursue potential strategic acquisitions.  ...
(Date:7/1/2015)... GAITHERSBURG, Md. , July 1, 2015 ... live biotherapeutics and probiotic treatments, announced today that it ... Canada Natural and Non-prescription Health Products Directorate (NNHPD) to ... Visbiome was developed by Professor Claudio ... subject of extensive clinical investigation. Professor De Simone recently ...
(Date:7/1/2015)... -- AVACEN, Inc. announced today the issue by the US Patent ... platform supporting its unique Dry Heat Therapy AVACEN 100 product. ... http://photos.prnewswire.com/prnh/20150630/227364LOGO ... Methods And Apparatus For Therapeutic Application of Thermal Energy shields ... use, referred to by the company as the AVACEN ...
Breaking Medicine Technology:Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3AVACEN Medical Patent Issued 2
... 11, 2011 Life Technologies Corporation (NASDAQ: ... of its intention to redeem all of the outstanding ... Notes") on June 15, 2011. As of May 6, ... the 2025 Convertible Notes outstanding. The redemption notice provided ...
... 2011 Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) ... its Equity Incentive Award Plan. ISS Proxy Advisory ... at the Company,s May 19, 2011 Annual Meeting of Shareholders ... Equity Incentive Award Plan.  ISS indicated that its "Against" recommendation ...
Cached Medicine Technology:Life Technologies Announces Redemption of 3.25% Convertible Senior Notes Due 2025 2Questcor Discusses ISS Proxy Recommendations; Provides Business Update 2Questcor Discusses ISS Proxy Recommendations; Provides Business Update 3Questcor Discusses ISS Proxy Recommendations; Provides Business Update 4Questcor Discusses ISS Proxy Recommendations; Provides Business Update 5
(Date:7/1/2015)... ... July 01, 2015 , ... A healthy eating ... chickens and eggs. Eating organic foods and products can help limit the exposure ... friendly than production chicken farming. Choosing home raised chickens and eggs that do ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... cancer enterprise of Hospital Corporation of America (HCA), as it further expands its ... announced today. , With this new partnership, OncLive’s editorial and marketing teams ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the widow ... on August 15-16th (MSG Keys’ birthday) in memory of her late husband and all ... and recipient of the Bronze Star Medal, died during a Special Forces training exercise ...
(Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. is ... released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the Health ... available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is a ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... law has just published a top ten list they hope will guide future ... Click here to read it now. , More than 450 mesothelioma ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2
... A group of researchers from Stanford have identified the nitric ... chemical events gradually resulting in the development of an embryo.He ... the sperm.// ,The research is based on the ... purple invertebrates found in the Pacific Ocean just a few ...
... flowing smoothly after angioplasty shows surprising success in early testing. ... the drug-coated stent. //In testing on 50 patients over 3 ... ,More than 2 million Americans undergo angioplasty annually, ... most of them if these promising results hold up in ...
... honey could prove effective in arresting the dental plaque ... New Zealand researcher will report at the American Association// ... enzyme in honey that produces hydrogen peroxide is the ... Dr. Peter C. Molan, associate professor of biochemistry at ...
... of Medicine have recently found that the brain's 'nose plug' ... stop smelling something, even though the odour is still there.// ... journal Science show that a protein called CNGA4 helps plug ... neurons is to detect smells and send that information to ...
... close to signing a deal to acquire the 51.5 per ... drugmaker Abbott Laboratories Inc. An industry source who declined to ... next few days to buy the stake in Abbott Laboratories ... officials from the company’s regional office in singapore will be ...
... heart surgery for patients in their mid-eighties and beyond ... for the elderly.// ,According to Dr. Todd Rosengart, ... heart surgery, if indicated, is safe and will improve ... of cardiac surgery at Southeastern Healthcare in Illinois. ...
Cached Medicine News:Health News:The route to fertilization, 2Health News:Heart Surgery Is Getting Safer for the Old 2
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
For the quantitative kinetic determination of amylase activity, using manual or automated procedures, in human serum and urine....
Intended for the quantitative determination of alphaamylase activity in serum. Single vial, dry powder reagent. Reaction: Kinetic. Wavelength: 405 nm. Linearity: 2000 U/L at 37C....
For the quantitative determination of Gamma-GT in serum. Kinetic Reaction measured at 405 nm. Linearity: 600 IU/L at 37C....
Medicine Products: